相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Nuclear PARP1 expression and its prognostic significance in breast cancer patients
Annalisa Mazzotta et al.
TUMOR BIOLOGY (2016)
Bioenergy and Breast Cancer: A Report on Tumor Growth and Metastasis
Alice Running et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients
Xiaorong Zhong et al.
PLOS ONE (2016)
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
Bernard Pereira et al.
NATURE COMMUNICATIONS (2016)
Network Meta-Analysis of the Effectiveness of Neoadjuvant Endocrine Therapy for Postmenopausal, HR-Positive Breast Cancer
Wei Wang et al.
SCIENTIFIC REPORTS (2016)
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
Giovanni Ciriello et al.
CELL (2015)
Therapeutic Touch Has Significant Effects on Mouse Breast Cancer Metastasis and Immune Responses but Not Primary Tumor Size
Gloria Gronowicz et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis
Otto L. D. Cerqueira et al.
ONCOTARGET (2015)
Biological and clinical significance of PARP1 protein expression in breast cancer
Andrew R. Green et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer
Tarek M. A. Abdel-Fatah et al.
MOLECULAR ONCOLOGY (2015)
Comparative Efficacy and Tolerability of Three Treatments in Old People with Osteoporotic Vertebral Compression Fracture: A Network Meta-Analysis and Systematic Review
Ling-Xiao Chen et al.
PLOS ONE (2015)
Silencing of Fanconi Anemia Complementation Group F Exhibits Potent Chennosensitization of Mitomycin C Activity in Breast Cancer Cells
Jiankun Yu et al.
JOURNAL OF BREAST CANCER (2013)
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Kelly-Anne Phillips et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The ATM protein kinase: regulating the cellular response to genotoxic stress, and more
Yosef Shiloh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Evidence Synthesis for Decision Making 2: A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials
Sofia Dias et al.
MEDICAL DECISION MAKING (2013)
Graphical Tools for Network Meta-Analysis in STATA
Anna Chaimani et al.
PLOS ONE (2013)
PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients
Flavia R. Mangone et al.
CLINICS (2012)
A bayesian network meta-analysis on comparisons of enamel matrix derivatives, guided tissue regeneration and their combination therapies
Yu-Kang Tu et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2012)
Rad51 Promoter-Targeted Gene Therapy Is Effective for In Vivo Visualization and Treatment of Cancer
Christopher M. Hine et al.
MOLECULAR THERAPY (2012)
Gene Silencing of FANCF Potentiates the Sensitivity to Mitoxantrone through Activation of JNK and p38 Signal Pathways in Breast Cancer Cells
Yanlin Li et al.
PLOS ONE (2012)
Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome
Valerie Bonadona et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
Georgia Salanti et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: Clinical and prognostic implications
Satyabrata Sinha et al.
MOLECULAR ONCOLOGY (2011)
Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1
Jeroen P. Jansen et al.
VALUE IN HEALTH (2011)
PIK3CA Mutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer
Shuji Ogino et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases
Paul O. Hassa et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Use of the Rad51 promoter for targeted anti-cancer therapy
Christopher M. Hine et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Reduced host cell reactivation of oxidative DNA damage in human cells deficient in the mismatch repair gene hMSH2
Photini Pitsikas et al.
MUTAGENESIS (2007)
Dual induction of apoptosis and senescence in cancer cells by Chk2 activation: Checkpoint activation as a strategy against cancer
CR Chen et al.
CANCER RESEARCH (2005)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
ATM and genome maintenance: Defining its role in breast cancer susceptibility
KK Khanna et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2004)